ABBV-1882
ABBV-1882 is a combination of ABBV-181 (anti-PD1) and ABBV-382 (anti-a4b7 mAb) being investigated for a functional cure to HIV.
Type of Molecule
BiologicTarget
anti-PD1 and anti-a4b7 mAbProduct Type
New Indication| Potential Indication | Region | Phase (1, 2, 3, Submitted) |
|---|---|---|
| HIV | n/a |
Phase 1
|